Adaptive Biotechnologies
ADPT
#4449
Rank
NZ$3.89 B
Marketcap
NZ$25.51
Share price
-15.52%
Change (1 day)
131.27%
Change (1 year)

Market capitalization of Adaptive Biotechnologies (ADPT)

Market cap: NZ$3.89 Billion

As of December 2025 Adaptive Biotechnologies has a market cap of NZ$3.89 Billion. This makes Adaptive Biotechnologies the world's 4449th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptive Biotechnologies from 2019 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$3.89 B136.6%
2024NZ$1.64 B46.73%
2023NZ$1.12 B-34.82%
2022NZ$1.72 B-70.32%
2021NZ$5.79 B-48.27%
2020NZ$11.20 B101.45%
2019NZ$5.56 B

End of Day market cap according to different sources

On Dec 7th, 2025 the market cap of Adaptive Biotechnologies was reported to be:

NZ$3.89 Billion
by Nasdaq info icon info icon
NZ$3.89 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HCA Healthcare
HCA
NZ$196.95 B 4,957.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
NZ$4.04 B 3.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Community Health Systems
CYH
NZ$0.86 B-77.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Select Medical Holdings
SEM
NZ$3.19 B-17.90%๐Ÿ‡บ๐Ÿ‡ธ USA